Alaunos Therapeutics Files DEF 14A for 2024
Ticker: TCRT · Form: DEF 14A · Filed: May 21, 2025 · CIK: 1107421
| Field | Detail |
|---|---|
| Company | Alaunos Therapeutics, INC. (TCRT) |
| Form Type | DEF 14A |
| Filed Date | May 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: DEF 14A, executive-compensation, corporate-governance
TL;DR
Alaunos Therapeutics (AL耺) filed its 2024 DEF 14A. Look out for exec comp details.
AI Summary
Alaunos Therapeutics, Inc. filed a DEF 14A on May 21, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. The company, formerly known as ZIOPHARM ONCOLOGY INC, is based in Houston, TX.
Why It Matters
This filing provides crucial information for shareholders regarding executive pay and company governance, impacting investor confidence and decision-making.
Risk Assessment
Risk Level: medium — DEF 14A filings often contain information about executive compensation and corporate governance that can signal potential risks or opportunities for investors.
Key Numbers
- 2024 — Fiscal Year (Reporting period for executive compensation and governance details.)
- 2023 — Fiscal Year (Comparative data for executive compensation and governance.)
Key Players & Entities
- Alaunos Therapeutics, Inc. (company) — Filer
- ZIOPHARM ONCOLOGY INC (company) — Former Company Name
- 20250521 (date) — Filing Date
- 20250703 (date) — Period of Report
- 1231 (date) — Fiscal Year End
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information regarding the company's annual meeting, including details on executive compensation, director nominations, and other corporate governance matters.
When was this DEF 14A filing submitted?
This DEF 14A filing was submitted on May 21, 2025.
What is Alaunos Therapeutics, Inc.'s fiscal year end?
Alaunos Therapeutics, Inc.'s fiscal year ends on December 31.
Has Alaunos Therapeutics, Inc. operated under a different name previously?
Yes, the company was formerly known as ZIOPHARM ONCOLOGY INC.
What is the SEC file number for Alaunos Therapeutics, Inc.?
The SEC file number for Alaunos Therapeutics, Inc. is 001-33038.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 21, 2025 regarding Alaunos Therapeutics, Inc. (TCRT).